Singapore markets open in 4 hours 46 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
292.39-2.53 (-0.86%)
At close: 4:00PM EDT
292.50 +0.11 (+0.04%)
After hours: 04:12PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 567.50B
Enterprise value 366.74B
Trailing P/E 15.10
Forward P/E 16.13
PEG Ratio (5 yr expected) 10.05
Price/sales (ttm)8.10
Price/book (mrq)10.57
Enterprise value/revenue 38.59
Enterprise value/EBITDA 711.67

Trading information

Stock price history

Beta (5Y monthly) -1.16
52-week change 3251.30%
S&P500 52-week change 334.68%
52-week high 3464.00
52-week low 375.35
50-day moving average 3295.49
200-day moving average 3259.12

Share statistics

Avg vol (3-month) 34.14M
Avg vol (10-day) 32.81M
Shares outstanding 5242.52M
Implied shares outstanding 6N/A
Float 877.79M
% held by insiders 11.15%
% held by institutions 116.58%
Shares short (29 Sep 2021) 42.29M
Short ratio (29 Sep 2021) 40.71
Short % of float (29 Sep 2021) 4N/A
Short % of shares outstanding (29 Sep 2021) 40.94%
Shares short (prior month 30 Aug 2021) 42.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 52.41%
Operating margin (ttm)71.20%

Management effectiveness

Return on assets (ttm)68.31%
Return on equity (ttm)133.85%

Income statement

Revenue (ttm)7.77B
Revenue per share (ttm)31.98
Quarterly revenue growth (yoy)12,630.20%
Gross profit (ttm)-222.04M
EBITDA 5.58B
Net income avi to common (ttm)4.07B
Diluted EPS (ttm)17.98
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)914.9M
Total cash per share (mrq)3.75
Total debt (mrq)256.8M
Total debt/equity (mrq)4.68
Current ratio (mrq)2.67
Book value per share (mrq)22.47

Cash flow statement

Operating cash flow (ttm)-354.87M
Levered free cash flow (ttm)-1.08B